Provided by Tiger Trade Technology Pte. Ltd.

Gain Therapeutics, Inc.

3.98
+0.12003.11%
Volume:86.15K
Turnover:332.10K
Market Cap:153.08M
PE:-6.25
High:3.98
Open:3.85
Low:3.78
Close:3.86
52wk High:4.34
52wk Low:1.41
Shares:38.46M
Float Shares:37.12M
Volume Ratio:2.17
T/O Rate:0.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6370
EPS(LYR):-0.8920
ROE:-261.72%
ROA:-86.79%
PB:25.90
PE(LYR):-4.46

Loading ...

LIVE MARKETS-Stocks gain, yields little changed after Fed's hawkish cut

Reuters
·
Dec 11

Gain Therapeutics Announces New Stock Offering Program

TIPRANKS
·
Nov 29

BRIEF-Gain Therapeutics Files Prospectus For $35.5 Million Stock Sale - SEC Filing

Reuters
·
Nov 29

Gain Therapeutics Inc - Files Prospectus for $35.5 Mln Stock Sale - SEC Filing

THOMSON REUTERS
·
Nov 29

Gain Therapeutics Unveils Preclinical Data Showing GT-02287 Boosts Mitochondrial Function in Parkinson’s Models

Reuters
·
Nov 20

Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2025

GlobeNewswire
·
Nov 20

Positive Outlook for Gain Therapeutics: Promising Clinical Trial Results and Stable Financial Health Drive Buy Rating

TIPRANKS
·
Nov 16

Gain Therapeutics Reports Continued Progress Amid Financial Challenges

TIPRANKS
·
Nov 13

Gain Therapeutics Q3 EPS $(0.15) Beats $(0.16) Estimate

Benzinga
·
Nov 12

Gain Therapeutics Q3 EPS USD -0.15

THOMSON REUTERS
·
Nov 12

Gain Therapeutics Completes Phase 1b Enrollment and Reports Q3 2025 Results

Reuters
·
Nov 12

Press Release: Gain Therapeutics Reports Financial Results for Third Quarter 2025 and Provides Corporate Update

Dow Jones
·
Nov 12

Gain Therapeutics Unveils GT-02287 Parkinson’s Therapy Data at Neuroscience 2025

Reuters
·
Oct 30

Gain Therapeutics to Attend the 2025 Maxim Growth Summit

GlobeNewswire
·
Oct 16

Gain Therapeutics Inc : Btig Cuts Target Price to $5 From $9

THOMSON REUTERS
·
Oct 16

Analysts Are Bullish on These Healthcare Stocks: Candel Therapeutics (CADL), Gain Therapeutics (GANX)

TIPRANKS
·
Oct 15

Gain Therapeutics Price Target Maintained With a $9.00/Share by BTIG

Dow Jones
·
Oct 15

Gain Therapeutics Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
Oct 13

Gain Therapeutics Inc reduces board size to seven after Eric Richman resignation

Reuters
·
Oct 10

Gain Therapeutics to Host Virtual KOL Event Highlighting GT02287 Data for Parkinsons Disease

Reuters
·
Oct 09